Trade Mark Journal No.2025/050 12 December 2025
WO0000001889110 (5,44)
Office of origin: United States of America
Date of International Registration:27 October 2025
Date of designation in the UK:
27 October 2025

International priority date claimed: 10 July 2025
(United States of America)
(99277251)
- Class 5
- Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of graft versus host disorder (gvhd); pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of dermatological disorders; pharmaceutical preparations for the treatment of fibrotic disorders.
- Class 44
- Providing medical information via a website.
Incyte Holdings Corporation
Representative: Makiko Coffland Christensen O'Connor Johnson Kindness, 1201 Third Avenue, Suite 3600, Seattle WA 98101, UNITED STATES OF AMERICA